California Public Employees Retirement System’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-241,871
| Closed | -$5.9M | – | 1242 |
|
|
2021
Q2 | $5.9M | Sell |
241,871
-26,312
| -10% | -$594K | ﹤0.01% | 1192 |
|
|
2021
Q1 | $6.92M | Buy |
268,183
+15,612
| +6% | +$687K | 0.01% | 1257 |
|
|
2020
Q4 | $13.5M | Buy |
252,571
+727
| +0.3% | +$36.1K | 0.01% | 838 |
|
|
2020
Q3 | $10.4M | Buy |
251,844
+7,850
| +3% | +$339K | 0.01% | 828 |
|
|
2020
Q2 | $11.8M | Sell |
243,994
-7,091
| -3% | -$340K | 0.01% | 736 |
|
|
2020
Q1 | $10.6M | Sell |
251,085
-28,642
| -10% | -$1.18M | 0.01% | 657 |
|
|
2019
Q4 | $12M | Buy |
279,727
+57,324
| +26% | +$2.49M | 0.01% | 855 |
|
|
2019
Q3 | $8M | Buy |
222,403
+97,232
| +78% | +$2.95M | 0.01% | 977 |
|
|
2019
Q2 | $3.35M | Buy |
125,171
+20,571
| +20% | +$525K | ﹤0.01% | 1369 |
|
|
2019
Q1 | $2.81M | Sell |
104,600
-1,500
| -1% | -$35K | ﹤0.01% | 1553 |
|
|
2018
Q4 | $1.72M | Sell |
106,100
-10,500
| -9% | -$204K | ﹤0.01% | 1826 |
|
|
2018
Q3 | $2.42M | Sell |
116,600
-9,600
| -8% | -$151K | ﹤0.01% | 1790 |
|
|
2018
Q2 | $1.93M | Sell |
126,200
-25,300
| -17% | -$451K | ﹤0.01% | 1923 |
|
|
2018
Q1 | $3.4M | Sell |
151,500
-7,300
| -5% | -$202K | ﹤0.01% | 1551 |
|
|
2017
Q4 | $4.78M | Buy |
158,800
+5,600
| +4% | +$179K | 0.01% | 1403 |
|
|
2017
Q3 | $5.77M | Buy |
153,200
+2,800
| +2% | +$91.1K | 0.01% | 1220 |
|
|
2017
Q2 | $4.2M | Buy |
150,400
+3,300
| +2% | +$98.3K | 0.01% | 1391 |
|
|
2017
Q1 | $5.06M | Sell |
147,100
-6,400
| -4% | -$226K | 0.01% | 1269 |
|
|
2016
Q4 | $4.43M | Hold |
153,500
| – | – | 0.01% | 1368 |
|
|
2016
Q3 | $4.88M | Sell |
153,500
-10,600
| -6% | -$359K | 0.01% | 1310 |
|
|
2016
Q2 | $5.33M | Sell |
164,100
-5,100
| -3% | -$171K | 0.01% | 1242 |
|
|
2016
Q1 | $4.73M | Sell |
169,200
-24,800
| -13% | -$541K | 0.01% | 1324 |
|
|
2015
Q4 | $6.92M | Buy |
194,000
+900
| +0.5% | +$31.7K | 0.01% | 1050 |
|
|
2015
Q3 | $6.39M | Hold |
193,100
| – | – | 0.01% | 1099 |
|
|
2015
Q2 | $8.09M | Sell |
193,100
-4,823
| -2% | -$187K | 0.01% | 1035 |
|
|
2015
Q1 | $6.27M | Hold |
197,923
| – | – | 0.01% | 1249 |
|
|
2014
Q4 | $6.27M | Buy |
197,923
+22,775
| +13% | +$646K | 0.01% | 1249 |
|
|
2014
Q3 | $4.34M | Sell |
175,148
-6,217
| -3% | -$145K | 0.01% | 1495 |
|
|
2014
Q2 | $4.1M | Buy |
181,365
+3,710
| +2% | +$77.5K | 0.01% | 1620 |
|
|
2014
Q1 | $3.73M | Sell |
177,655
-19,595
| -10% | -$496K | 0.01% | 1644 |
|
|
2013
Q4 | $5.02M | Buy |
197,250
+39,650
| +25% | +$935K | 0.01% | 1410 |
|
|
2013
Q3 | $4.33M | Buy |
157,600
+31,250
| +25% | +$653K | 0.01% | 1351 |
|
|
2013
Q2 | $2.29M | Buy |
+126,350
| New | +$1.74M | ﹤0.01% | 1665 |
|
Other funds holding ACAD
BBA
PAI
California Public Employees Retirement System's ACAD Position: Q3 2021 in Review
California Public Employees Retirement System sold out of Acadia Pharmaceuticals (ACAD) in Q3 2021, closing a stake of 241,871 shares — an estimated $5.9M sold.
California Public Employees Retirement System first reported a position in ACAD in Q2 2013 and held it in 33 quarters. The position peaked at $13.5M in Q4 2020. 236 funds tracked by Wall St. Rank hold ACAD as of Q3 2021.
- California Public Employees Retirement System reported no remaining Acadia Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
- California Public Employees Retirement System sold 241,871 Acadia Pharmaceuticals shares in Q3 2021, an estimated $5.9M.
- California Public Employees Retirement System first reported a position in Acadia Pharmaceuticals in Q2 2013 and held it in 33 quarters.
- California Public Employees Retirement System's Acadia Pharmaceuticals position peaked at $13.5M in Q4 2020.
- 236 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q3 2021.
Based on California Public Employees Retirement System's 13F filing for Q3 2021, filed 10 Nov 2021.